SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

Immunotherapeutic strategies including the blockade of programmed death 1 (PD-1) receptors hold promise for the treatment of various cancers including non-small cell lung carcinoma (NSCLC). Preclinical data suggest that pre-existing tumor immunity is important for disease regression upon checkpoint...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782159/
https://ncbi.nlm.nih.gov/pubmed/24073380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25205
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars